Top Markets
#1 Islamic Coin Islamic Coin +154.34%
#2 PulseChain PulseChain +51.99%
#3 BOOK OF MEME BOOK OF MEME +43.75%
#4 DogBull DogBull +34.41%
#5 ORDI ORDI +19.01%
#6 Ergo Ergo +18.18%
#7 Nockchain Nockchain +17.41%
#8 rsERG rsERG +16.56%
#9 RedStone RedStone +15.97%
#10 Victoria VR Victoria VR +15.41%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Rank in Stocks #27070
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Share Price
$2.04
Last synced: 2025-12-09
Market Cap
$35.38M
Change (1 day)
0.00%
Change (1 year)
-2.39%
Country
IE
Trade Mural Oncology plc (MURA)

Category

Healthcare
Number of shares outstanding for Mural Oncology plc (MURA)
Number of shares outstanding as of August 2026: 0
According to Mural Oncology plc latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Mural Oncology plc (MURA) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH